mRNA vaccines: will they meet expectations?

Folia Pharmaceutica – Vaccines

Author: Prof. Dr. Gideon Kersten

After Covid-19 spread lightning-fast over the globe, the development and provisional approval of effective vaccines almost went as fast. Among the frontrunners were mRNA vaccines. They are safe and had an efficacy above 90% after two immunizations (Soheili 2023). Therefore, the expectations for future vaccines based on mRNA vaccines are high.

Read the full article on page 24 of this magazine:

Folia Pharmaceutica December edition Vaccines by FoliaPharmaceutica – Issuu